An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Researchers are reporting that drugs like Ozempic and Wegovy can help people keep eating fewer calories for more than a year. That’s the basic news: in studies, people taking these GLP-1 medications were able to sustain a lower daily calorie intake over long stretches, rather than the short-lived appetite changes people sometimes expect from diet drugs. GLP-1s are a class of medicines made to act like a natural hormone in your gut called glucagon-like peptide-1. In plain terms, they make you feel less hungry and help you feel full sooner. Semaglutide is one of the medicines in this group — it’s the active ingredient in Ozempic and Wegovy. Doctors originally used these drugs for diabetes and then for weight management because they slow the rate food leaves the stomach and change signals between the gut and the brain about fullness. What the reports describe is that in the studies, people on these GLP-1 drugs didn’t just eat less for a few weeks — their reduced calorie intake held up for a year or longer. The coverage doesn’t claim magic; instead it notes a sustained effect on how much people voluntarily ate. It’s important to know whether the studies were done in large numbers of people or smaller clinical trials, but the headline takeaway is that the appetite-suppressing effects lasted well beyond the short term in the research cited. Why this matters is straightforward: maintaining a lower calorie intake is the hard part of long-term weight control. Many diets work briefly but fail because hunger and cravings return. If a medicine can safely help people consistently eat less over months to years, it could make it easier to lose weight and keep it off, and to improve conditions linked to excess weight such as type 2 diabetes or high blood pressure. People trying to manage weight, or clinicians looking for long-term tools beyond lifestyle changes alone, would pay attention to this. There are important caveats. These drugs can have side effects — common ones include nausea, diarrhea, and stomach upset — and long-term safety still gets studied. The benefits usually require ongoing treatment; stopping the drug often leads to weight regain. They’re prescription medications, not over-the-counter supplements, and they should be used under a doctor’s supervision. Also, individual responses vary: not everyone will have the same appetite reduction or health outcomes. Bottom line: GLP-1 drugs like semaglutide appear able to help people eat fewer calories for a year or more, which could support sustained weight loss, but they come with side effects, require medical oversight, and aren’t a standalone cure.
Source: Healthline